Intermediate declaration by the Board of Directors
Regulatory News:
X-FAB (BOURSE:XFAB):
Highlights Q2 2025:
- Revenue was USD 215.3 million, up 5% year-on-year (YoY) and up 5% quarter-on-quarter (QoQ)
- Excluding the impact from revenue recognized over time (IFRS 15), revenue was USD 218.3 million, well above the guided range of USD 200-210 million
- Bookings at USD 207.2 million reflecting again a strong sequential increase of 19% QoQ
- EBITDA at USD 51.6 million, up 7% YoY and up 4% QoQ
- EBITDA margin of 24.0%; excluding IFRS 15 impact, EBITDA margin was 24.3%, compared to the guidance of 22.5-25.5%
- EBIT was USD 21.7 million, down 6% YoY and up 2% QoQ
Outlook:
- Q3 2025 revenue is expected to come in within a range of USD 215-225 million with an EBITDA margin in the range of 22.5% and 25.5%.
- The guidance is based on an average exchange rate of 1.17 USD/Euro and does not take into account the impact of IFRS 15.
- X-FAB upgrades its FY 2025 guidance, projecting annual revenue in the range of USD 840-870 million, with an anticipated EBITDA margin between 24% and 27%.
Revenue breakdown per quarter:
in millions of USD | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q2 y-o-y growth |
Automotive | 135.3 | 151.8 | 135.6 | 142.4 | 146.0 | 128.6 | 135.4 | 143.4 | 1% |
Industrial | 53.7 | 54.3 | 52.6 | 34.4 | 31.5 | 36.1 | 39.3 | 47.2 | 37% |
Medical | 17.0 | 16.4 | 14.5 | 13.2 | 12.1 | 16.5 | 13.8 | 15.1 | 14% |
Subtotal core business | 206.1 | 222.5 | 202.6 | 190.1 | 189.6 | 181.2 | 188.6 | 205.7 | 8% |
92.2% | 92.8% | 92.6% | 93.7% | 92.9% | 92.1% | 93.2% | 94.2% | ||
CCC1 | 17.2 | 17.2 | 16.0 | 12.6 | 14.2 | 15.1 | 13.6 | 12.2 | -4% |
Others | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.5 | 0.2 | 0.4 | |
Revenue* | 223.5 | 239.8 | 218.7 | 202.8 | 204.0 | 196.8 | 202.3 | 218.3 | 8% |
Impact from revenue recognized over time | 10.4 | -2.0 | -2.6 | 2.3 | 2.4 | -8.0 | 1.8 | -3.0 | |
Total revenue | 233.8 | 237.7 | 216.2 | 205.1 | 206.4 | 188.8 | 204.1 | 215.3 | 5% |
1Consumer, Communications Computer | |||||||||
in millions of USD | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q2 y-o-y growth |
CMOS | 180.5 | 188.4 | 168.3 | 166.2 | 175.0 | 170.8 | 173.4 | 185.1 | 11% |
Microsystems | 24.4 | 27.9 | 24.1 | 25.1 | 21.6 | 20.2 | 22.9 | 25.3 | 1% |
Silicon carbide | 18.6 | 23.5 | 26.3 | 11.6 | 7.4 | 5.8 | 6.0 | 7.9 | -31% |
Revenue* | 223.5 | 239.8 | 218.7 | 202.8 | 204.0 | 196.8 | 202.3 | 218.3 | 8% |
Impact from revenue recognized over time | 10.4 | -2.0 | -2.6 | 2.3 | 2.4 | -8.0 | 1.8 | -3.0 | |
Total revenue | 233.8 | 237.7 | 216.2 | 205.1 | 206.4 | 188.8 | 204.1 | 215.3 | 5% |
Business development
In the second quarter of 2025, X-FAB recorded revenues of USD 215.3 million, up 5% year-on-year and up 5% quarter-on-quarter. Excluding the impact from revenue recognized over time in the amount of USD -3.0 million, quarterly revenue was USD 218.3 million, which is well above the guidance of USD 200-210 million. Second quarter revenue in X-FAB's core markets automotive, industrial, and medical was at USD 205.7 million*, up 8% year-on-year and up 9% quarter-on-quarter, representing a share of 94%* of total revenue.
2025 is progressing more favorably than initially anticipated, and X-FAB upgrades its full-year revenue guidance to USD 840-870 million, up from the previous range of USD 820-870 million. Order intake has increased strongly for two consecutive quarters, with second-quarter bookings reaching USD 207.2 million, up 19% from the previous quarter.
As X-FAB's business is no longer constrained by capacity and factory cycle times have shortened, customers place orders later than usual and more frequently at short notice, resulting in a reduced visibility.
The backlog for the second quarter amounted to USD 412.9 million, compared to USD 386.7 million at the end of the previous quarter.
In the second quarter, automotive revenue totaled USD 143.4 million*, up 1% year-on-year and up 6% sequentially, mainly driven by EV-related applications. Industrial revenue came in at USD 47.2 million*, recording a strong growth of 37% year-on-year and 20% quarter-on-quarter. The highly fragmented industrial end-market is picking up again. X-FAB's industrial business also benefited from increased demand following the last-time-buy announcement for some of X-FAB's 150mm CMOS technologies, as well as from revenue generated by prototyping new customer projects. X-FAB's medical business recorded a quarterly revenue of USD 15.1 million*, up 14% year-on-year and up 9% quarter-on-quarter. Growth in the second quarter was mainly driven by medical-grade contactless temperature sensors.
In the second quarter, X-FAB reported a sequential increase in revenue across all technologies for the second consecutive quarter. The year-on-year revenue growth in the second quarter was primarily related to an 11%* rise in CMOS revenue. Microsystems revenue increased by 1%* compared to the previous year, while silicon carbide (SiC) revenue decreased by 31%* year-on-year.
The gradual recovery of X-FAB's SiC business is not fully reflected in the evolution of the top line. Sequentially, SiC revenue rose by 32%*, while the number of SiC wafers produced grew by more than 60% quarter-on-quarter. This is due to the greater proportion of SiC raw wafers being supplied to X-FAB by its customers, which results in lower total billing since there is less pass-through for substrates sourced directly by X-FAB. During the first half of 2025, X-FAB started production of more SiC wafers in its factory in Texas than it did throughout all of 2024, primarily due to demand from data center applications.
Quarterly prototyping revenue was USD 21.0 million*, down 1% year-on-year and up 30% quarter-on-quarter. The achievement of key milestones in customer-specific microsystems projects has significantly contributed to the strong increase compared to the previous quarter.
Prototyping and production revenue* per quarter and end market:
in millions of USD | Revenue | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
Automotive | Prototyping | 7.6 | 9.3 | 8.9 | 4.7 | 5.1 |
Production | 134.8 | 136.7 | 119.7 | 130.8 | 138.2 | |
Industrial | Prototyping | 8.9 | 8.2 | 9.6 | 8.8 | 12.1 |
Production | 25.5 | 23.3 | 26.5 | 30.5 | 35.2 | |
Medical | Prototyping | 2.0 | 3.0 | 2.3 | 1.5 | 1.8 |
Production | 11.2 | 9.1 | 14.2 | 12.3 | 13.2 | |
CCC | Prototyping | 2.5 | 3.0 | 2.6 | 1.1 | 1.7 |
Production | 10.2 | 11.3 | 12.6 | 12.5 | 10.5 |
Operations update
The end of the second quarter marks the completion of X-FAB's three-year program to expand manufacturing capacities across the Group. Main focus in the first half of the year was on equipping the new clean room in Kuching, Malaysia. All equipment has been delivered and is at different stages of installation and qualification. A number of tools and machines have successfully completed qualification, allowing for a phased ramp-up of X-FAB's 180nm CMOS production from the third quarter onward. The expansion provides sufficient capacity to serve current and future customer demand for this popular technology, which is key to supporting X-FAB's CMOS and microsystems business going forward.
Capital expenditures in the second quarter amounted to USD 53.7 million, reflecting a 47% decline from the previous quarter. For the first half of 2025, capital expenditures totaled USD 155.5 million, coming in slightly lower than expected due to the deferral of some expenditures to the second half of the year. The full-year capital expenditure projection remains unchanged at USD 250 million.
Financial update
Second quarter EBITDA was USD 51.6 million with an EBITDA margin of 24.0%. Excluding the impact from revenues recognized over time, the EBITDA margin for the second quarter would have been 24.3%, within the guided range of 22.5-25.5%.
Profitability remains unaffected by exchange rate fluctuations as X-FAB's business is naturally hedged. At a constant USD/Euro exchange rate of 1.08 as experienced in the previous year's quarter, the EBITDA margin would have been at the same level.
For the financial result in the second quarter X-FAB recorded a loss of USD 17.4 million, which includes an unrealized foreign exchange effect totaling USD -17.2 million (non-cash), primarily related to the reevaluation of Euro-denominated debt.
Cash and cash equivalents at the end of the second quarter amounted to USD 157.7 million, nearly unchanged from the previous quarter.
Management comments
Rudi De Winter, CEO of X-FAB Group, said: "We are presenting a solid set of results for the second quarter and expect this positive trend to continue in the second half of the year. I am particularly pleased about the above-average order intake for our microsystems business. It stands for highly complex applications that help to save lives in the medical sector or by improving road safety. With the completion of our capacity expansion program, we are ideally positioned to grow profitably together with our customers. Sufficient capacity is now available for our most popular technologies, suited to address the megatrends of our time, such as the electrification of everything. This will generate high demand in the long term despite a currently reduced visibility."
Procedures of the independent auditor
The statutory auditor, KPMG Bedrijfsrevisoren Réviseurs d'Entreprises BV/SRL, represented by Herwig Carmans, has confirmed that the review procedures, which have been substantially completed, have not revealed any material misstatement in the accounting information included in this press release as of and for the six months ended June 30, 2025.
X-FAB Quarterly Conference Call
X-FAB's second quarter results will be discussed in a live conference call/audiocast on Thursday, July 31, 2025, at 6.30 p.m. CEST. The conference call will be in English.
Please register here for the audiocast (listen only).
Please register here for the conference call (listen and ask questions).
Financial calendar
September 2, 2025 | Publication of Half-Year Report 2025 |
September 9, 2025 | X-FAB Investor Day 2025 |
October 30, 2025 | Publication of Q3 2025 results |
About X-FAB
X-FAB is a global foundry group providing a comprehensive set of specialty technologies and design IP to enable its customers to develop world-leading semiconductor products that are manufactured at X-FAB's six wafer fabs located in Malaysia, Germany, France, and the United States. With its expertise in analog/mixed-signal technologies, microsystems/MEMS and silicon carbide (SiC), X-FAB is the development and manufacturing partner for its customers, primarily serving the automotive, industrial and medical end markets. X-FAB has approximately 4,500 employees and has been listed on Euronext Paris since April 2017 (XFAB). For more information, please visit www.xfab.com.
Forward-looking information
This press release may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management's current intentions, beliefs or expectations relating to, among other things, X-FAB's future results of operations, financial condition, liquidity, prospects, growth, strategies, or developments in the industry in which we operate. By their nature, forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results or future events to differ materially from those expressed or implied thereby. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.
Forward-looking statements contained in this press release regarding trends or current activities should not be taken as a report that such trends or activities will continue in the future. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless legally required. You should not place undue reliance on any such forward-looking statements, which speak only as of the date of this press release.
The information contained in this press release is subject to change without notice. No re-report or warranty, express or implied, is made as to the fairness, accuracy, reasonableness, or completeness of the information contained herein and no reliance should be placed on it.
Condensed consolidated statement of profit and loss
in thousands of USD | Quarter ended unaudited | Quarter ended unaudited | Quarter ended unaudited | Half-year ended unaudited | Half-year ended unaudited |
Revenue* | 218,275 | 202,847 | 202,332 | 420,607 | 421,559 |
Impact from revenue recognized over time | -2,992 | 2,255 | 1,781 | -1,211 | -305 |
Total revenue | 215,283 | 205,102 | 204,113 | 419,396 | 421,254 |
Revenues in USD in | 56 | 58 | 58 | 57 | 60 |
Revenues in EUR in | 44 | 42 | 42 | 43 | 40 |
Cost of sales | -165,350 | -160,236 | -159,476 | -324,826 | -326,022 |
Gross profit | 49,933 | 44,866 | 44,636 | 94,570 | 95,232 |
Gross profit margin in % | 23.2 | 21.9 | 21.9 | 22.5 | 22.6 |
Research and development expenses | -13,458 | -11,387 | -10,992 | -24,450 | -22,494 |
Selling expenses | -2,407 | -2,142 | -2,248 | -4,655 | -4,679 |
General and administrative expenses | -13,393 | -11,660 | -11,397 | -24,791 | -24,471 |
Rental income and expenses from investment properties | 785 | 394 | 776 | 1,561 | 1,828 |
Other income and other expenses | 232 | 2,755 | 337 | 569 | 4,603 |
Operating profit | 21,693 | 22,825 | 21,112 | 42,805 | 50,019 |
Finance income | 19,612 | 6,775 | 6,494 | 26,106 | 12,552 |
Finance costs | -36,994 | -7,419 | -13,684 | -50,679 | -15,072 |
Financial result | -17,382 | -644 | -7,190 | -24,573 | -2,519 |
Profit before tax | 4,311 | 22,181 | 13,922 | 18,232 | 47,499 |
Income tax | -4,702 | -2,359 | -1,720 | -6,422 | -4,619 |
Profit for the period | -392 | 19,822 | 12,202 | 11,811 | 42,881 |
Operating profit (EBIT) | 21,693 | 22,825 | 21,112 | 42,805 | 50,019 |
Depreciation | 29,896 | 25,028 | 27,949 | 57,845 | 48,792 |
EBITDA | 51,589 | 47,853 | 49,061 | 100,650 | 98,811 |
EBITDA margin in % | 24.0 | 23.3 | 24.0 | 24.0 | 23.5 |
Earnings per share | 0.00 | 0.15 | 0.09 | 0.09 | 0.33 |
Weighted average number of shares | 130,631,921 | 130,631,921 | 130,631,921 | 130,631,921 | 130,631,921 |
EUR/USD average exchange rate | 1.13337 | 1.07667 | 1.05149 | 1.09279 | 1.08145 |
EUR/USD exchange rate on reporting date | 1.17040 | 1.07050 | 1.07970 | 1.17040 | 1.07050 |
Amounts in the financial tables provided in this press release are rounded to the nearest thousand except when otherwise indicated, rounding differences may occur. |
*excluding impact from revenue recognized over time in accordance with IFRS 15 |
Condensed consolidated statement of financial position
in thousands of USD | Quarter ended 30 Jun 2025 unaudited | Quarter ended 30 Jun 2024 unaudited | Year ended 31 Dec 2024 audited |
ASSETS | |||
Non-current assets | |||
Property, plant, and equipment | 1,224,295 | 879,363 | 1,144,620 |
Investment properties | 7,159 | 7,608 | 7,412 |
Intangible assets | 6,268 | 5,986 | 6,319 |
Other non-current assets | 33 | 50 | 42 |
Deferred tax assets | 64,380 | 83,173 | 66,725 |
Total non-current assets | 1,302,136 | 976,180 | 1,225,118 |
Current assets | |||
Inventories | 288,207 | 277,587 | 281,765 |
Contract assets | 16,880 | 23,706 | 18,092 |
Trade and other receivables | 111,612 | 108,980 | 96,648 |
Other assets | 73,470 | 46,918 | 69,253 |
Cash and cash equivalents | 157,678 | 290,054 | 215,837 |
Total current assets | 647,848 | 747,245 | 681,595 |
TOTAL ASSETS | 1,949,984 | 1,723,425 | 1,906,713 |
EQUITY AND LIABILITIES | |||
Equity | |||
Share capital | 432,745 | 432,745 | 432,745 |
Share premium | 348,709 | 348,709 | 348,709 |
Retained earnings | 253,776 | 223,604 | 241,648 |
Cumulative translation adjustment | 656 | -636 | 462 |
Treasury shares | -770 | -770 | -770 |
Total equity | 1,035,116 | 1,003,653 | 1,022,794 |
Non-current liabilities | |||
Non-current loans and borrowings | 418,230 | 244,604 | 369,616 |
Other non-current liabilities and provisions | 2,725 | 4,652 | 4,257 |
Total non-current liabilities | 420,955 | 249,256 | 373,873 |
Current liabilities | |||
Trade payables | 41,780 | 55,103 | 67,658 |
Current loans and borrowings | 54,041 | 26,272 | 44,517 |
Other current liabilities and provisions | 398,093 | 389,140 | 397,872 |
Total current liabilities | 493,914 | 470,516 | 510,046 |
TOTAL EQUITY AND LIABILITIES | 1,949,984 | 1,723,425 | 1,906,713 |
Condensed consolidated statement of cash flows
in thousands of USD | Quarter ended unaudited | Quarter ended unaudited | Quarter ended unaudited | Half-year ended unaudited | Half-year ended unaudited |
Income before taxes | 4,311 | 22,181 | 13,922 | 18,233 | 47,499 |
Reconciliation of income before taxes to cash flow arising from operating activities: | 52,164 | 28,972 | 30,949 | 83,113 | 52,704 |
Depreciation and amortization, before effect of grants and subsidies | 29,896 | 25,028 | 27,949 | 57,845 | 48,792 |
Amortization of investment grants and subsidies | -1,229 | -624 | -1,231 | -2,461 | -1,296 |
Interest income and expenses (net) | 8,475 | 959 | 3,756 | 12,231 | 653 |
Loss/(gain) on the sale of plant, property, and equipment (net) | -55 | -2,020 | -53 | -108 | -3,771 |
Loss/(gain) on the change in fair value of derivatives and financial assets (net) | -4,160 | 0 | 0 | -4,160 | 0 |
Other non-cash transactions (net) | 19,237 | 5,629 | 528 | 19,765 | 8,327 |
Changes in working capital: | -25,537 | 7,487 | -6,783 | -32,320 | 6,688 |
Decrease/(increase) of trade receivables | -16,471 | 10,211 | 1,296 | -15,175 | 18,463 |
Decrease/(increase) of other receivables and other assets | -6,646 | 12,244 | 6,562 | -85 | 18,831 |
Decrease/(increase) of inventories | -6,896 | -604 | 454 | -6,442 | -5,554 |
Decrease/(increase) of contract assets | 2,992 | -2,255 | -1,781 | 1,211 | 305 |
(Decrease)/increase of trade payables | -1,047 | -14,369 | -4,151 | -5,198 | -14,575 |
(Decrease)/increase of other liabilities | 2,532 | 2,260 | -9,163 | -6,631 | -10,780 |
Income taxes (paid)/received | -337 | -1,227 | -896 | -1,232 | -2,668 |
Net cash from operating activities | 30,602 | 57,413 | 37,192 | 67,794 | 104,224 |
Cash flow from investing activities: | |||||
Payments for property, plant, equipment and intangible assets | -53,726 | -121,893 | -101,731 | -155,456 | -226,873 |
Acquisition of subsidiary, net of cash acquired | 0 | -24,863 | 0 | 0 | -1,634 |
Proceeds from sale of property, plant, and equipment | 65 | 2,020 | 53 | 118 | 3,811 |
Interest received | 1,022 | 2,984 | 1,164 | 2,186 | 6,417 |
Net cash used in investing activities | -52,639 | -141,752 | -100,514 | -153,153 | -218,279 |
Condensed consolidated statement of cash flows con't
in thousands of USD | Quarter ended unaudited | Quarter ended unaudited | Quarter ended unaudited | Half-year ended unaudited | Half-year ended unaudited |
Cash flow from (used in) financing activities: | |||||
Proceeds from loans and borrowings | 21,668 | 42,601 | 28,902 | 50,571 | 92,901 |
Repayment of loans and borrowings | -17,469 | -5,644 | -21,081 | -38,551 | -99,757 |
Receipts of sale and leaseback arrangements | 26,925 | -5,147 | 3,095 | 30,020 | 26,469 |
Payments of lease installments | -9,131 | -3,061 | -4,146 | -13,277 | -4,230 |
Interest paid | -4,851 | -4,574 | -4,817 | -9,668 | -8,632 |
Cash flow from (used in) financing activities | 17,142 | 24,175 | 1,953 | 19,095 | 6,751 |
Effect of changes in foreign currency exchange rates on cash balances | 5,334 | -1,250 | 2,771 | 8,105 | -8,343 |
Increase/(decrease) of cash and cash equivalents | -4,895 | -60,164 | -61,368 | -66,263 | -107,304 |
Cash and cash equivalents at the beginning of the period | 157,240 | 351,468 | 215,837 | 215,837 | 405,701 |
Cash and cash equivalents at the end of the period | 157,678 | 290,054 | 157,240 | 157,678 | 290,054 |
*excluding impact from revenue recognized over time according to IFRS 15
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731726132/en/
Contacts:
X-FAB Press Contact
Uta Steinbrecher
Investor Relations
X-FAB Silicon Foundries
+49-361-427-6489
uta.steinbrecher@xfab.com
